Physician profile
Basem Badie Abdelmalak
NPI 1366403941
$147,291.51
in general payments reported to CMS, 2019-2025
15 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $1,430 · 2021: $24K · 2022: $7,991 · 2023: $43K · 2024: $55K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $100K · Consulting Fee: $5,720 · Food and Beverage: $2,713 · Honoraria: $2,000 · Travel and Lodging: $1,859 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $100,340.00 |
| Consulting Fee | $5,720.00 |
| Food and Beverage | $2,712.71 |
| Honoraria | $2,000.00 |
| Travel and Lodging | $1,858.75 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $94,905.65 | 2021-2025 | Mcgrath Mac, Microstream, Bis |
| Mindray Ds USA, INC. | $42,249.79 | 2022-2025 | A5 Anesthesia System, Na Electrode,Indirect,International, A7 Anesthesia System |
| Fresenius Kabi USA, LLC | $3,016.79 | 2020-2025 | Dilaudid, Fentanyl Citrate, Ivenix Infusion System |
| Ambu A/S | $2,266.66 | 2025 | |
| Henry Schein, INC. | $1,500.00 | 2024 | |
| Acacia Pharma INC | $1,029.50 | 2021-2022 | |
| Eagle Pharmaceuticals, INC. | $548.71 | 2023-2024 | |
| Covidien Lp | $480.00 | 2020 | |
| Edwards Lifesciences Corporation | $450.00 | 2022 | |
| Intuitive Surgical, INC. | $273.73 | 2023-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $208.30 | 2022-2023 | Exalt Model D |
| Getinge USA Sales, LLC | $142.86 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $92.32 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $92.00 | 2025 | |
| Ethicon INC. | $35.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basem Abdelmalak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.